January 17, 2019, Thursday
Acrotech will be acquiring the product portfolio on a debt free and cash free basis, Aurobindo Pharma Ltd said in a regulatory ...
January 07, 2019, Monday
The Hyderabad-based company is at fifth place in prescription sales, next to Indian counterpart Lupin, in the US
January 01, 2019, Tuesday
To date, Aurobindo Pharma USA Inc has not received any reports of adverse events related to this recall, the company said
December 27, 2018, Thursday
Analysts feel R&D costs are set to rise as a result of injectables and biosimilars focus
December 24, 2018, Monday
The approved product is a generic equivalent of Organon's Norcuron Injection
December 21, 2018, Friday
The potassium chloride tablets are for treating hypokalemia, a condition wherein there is a drop in the potassium-level in the ...
December 11, 2018, Tuesday
The JV will also undertake contract manufacturing for non-nebuliser inhaler products
December 05, 2018, Wednesday
In October, Aurobindo Pharma announced a voluntary recall of 22 batches of irbesartan due to the detection of trace amounts of ...
December 04, 2018, Tuesday
The stock hit a 52-week high of Rs 830, up 3%, surging 55% in past six months, as compared to 3% rise in the S&P BSE Sensex.
November 27, 2018, Tuesday
While revenue growth is expected to be strong, improving margins and reducing debt could be challenging
Copyrights © 2019 Business Standard Private Ltd. All rights reserved.
